SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,427,969 | +9.3% | 2,511,367 | +3.2% | 0.07% | +15.5% |
| Q2 2023 | $278,600,645 | +5.6% | 2,432,768 | +27.1% | 0.06% | 0.0% |
| Q1 2023 | $263,905,560 | +2.1% | 1,914,718 | -4.0% | 0.06% | -1.7% |
| Q4 2022 | $258,360,881 | +24.1% | 1,993,833 | +5.9% | 0.06% | +18.0% |
| Q3 2022 | $208,146,000 | +39.5% | 1,882,998 | -5.4% | 0.05% | +47.1% |
| Q2 2022 | $149,238,000 | -3.3% | 1,990,927 | +0.8% | 0.03% | +13.3% |
| Q1 2022 | $154,273,000 | -14.7% | 1,974,823 | -1.6% | 0.03% | -9.1% |
| Q4 2021 | $180,796,000 | -0.2% | 2,007,735 | +2.5% | 0.03% | -5.7% |
| Q3 2021 | $181,073,000 | +17.6% | 1,957,965 | -1.2% | 0.04% | +16.7% |
| Q2 2021 | $153,987,000 | +15.3% | 1,980,789 | +10.6% | 0.03% | +11.1% |
| Q1 2021 | $133,506,000 | -39.0% | 1,791,294 | +39.5% | 0.03% | -43.8% |
| Q4 2020 | $218,936,000 | +22.6% | 1,284,143 | +1.0% | 0.05% | +9.1% |
| Q3 2020 | $178,533,000 | -14.1% | 1,271,332 | -1.9% | 0.04% | -20.0% |
| Q2 2020 | $207,828,000 | +87.0% | 1,296,165 | +14.1% | 0.06% | +48.6% |
| Q1 2020 | $111,162,000 | -25.4% | 1,136,389 | -1.5% | 0.04% | -2.6% |
| Q4 2019 | $148,936,000 | +66.5% | 1,154,181 | -2.8% | 0.04% | +52.0% |
| Q3 2019 | $89,452,000 | -39.1% | 1,187,625 | +22.9% | 0.02% | -37.5% |
| Q2 2019 | $146,783,000 | +43.8% | 965,989 | +12.8% | 0.04% | +37.9% |
| Q1 2019 | $102,057,000 | +63.9% | 856,246 | +50.0% | 0.03% | +52.6% |
| Q4 2018 | $62,277,000 | +38.3% | 570,668 | +104.7% | 0.02% | +58.3% |
| Q3 2018 | $45,036,000 | +23.8% | 278,845 | +1.3% | 0.01% | +20.0% |
| Q2 2018 | $36,389,000 | +54.8% | 275,308 | -13.2% | 0.01% | +42.9% |
| Q1 2018 | $23,512,000 | +33.0% | 317,341 | -0.1% | 0.01% | +40.0% |
| Q4 2017 | $17,682,000 | +23.5% | 317,786 | +0.6% | 0.01% | +25.0% |
| Q3 2017 | $14,323,000 | +64.6% | 315,803 | +22.3% | 0.00% | +100.0% |
| Q2 2017 | $8,704,000 | +18.6% | 258,211 | +4.1% | 0.00% | 0.0% |
| Q1 2017 | $7,339,000 | +8.8% | 247,924 | +0.8% | 0.00% | 0.0% |
| Q4 2016 | $6,747,000 | -55.1% | 246,001 | +0.6% | 0.00% | -50.0% |
| Q3 2016 | $15,021,000 | +255.0% | 244,619 | +10.3% | 0.00% | +300.0% |
| Q2 2016 | $4,231,000 | -1.3% | 221,818 | +1.0% | 0.00% | 0.0% |
| Q1 2016 | $4,285,000 | -49.1% | 219,536 | +0.6% | 0.00% | -66.7% |
| Q4 2015 | $8,416,000 | +28.4% | 218,133 | +6.8% | 0.00% | +50.0% |
| Q3 2015 | $6,557,000 | -10.8% | 204,189 | -15.4% | 0.00% | 0.0% |
| Q2 2015 | $7,348,000 | +142.3% | 241,477 | +5.8% | 0.00% | +100.0% |
| Q1 2015 | $3,032,000 | +0.5% | 228,271 | +9.4% | 0.00% | 0.0% |
| Q4 2014 | $3,018,000 | -33.5% | 208,601 | -3.0% | 0.00% | 0.0% |
| Q3 2014 | $4,538,000 | -62.1% | 215,013 | -46.5% | 0.00% | -50.0% |
| Q2 2014 | $11,970,000 | +139.3% | 401,898 | +93.1% | 0.00% | +100.0% |
| Q1 2014 | $5,003,000 | +37.7% | 208,163 | +16.8% | 0.00% | 0.0% |
| Q4 2013 | $3,632,000 | -77.4% | 178,293 | -47.6% | 0.00% | -50.0% |
| Q3 2013 | $16,074,000 | +154.5% | 340,324 | +104.9% | 0.00% | 0.0% |
| Q2 2013 | $6,317,000 | – | 166,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |